Summary
Commonly reported side effects of ado-trastuzumab emtansine include: increased serum bilirubin, increased serum transaminases, cough, decreased platelet count, dyspnea, fatigue, fever, peripheral neuropathy, and thrombocytopenia. Other side effects include: chills. Continue reading for a comprehensive list of adverse effects.
Applies to ado-trastuzumab emtansine: intravenous powder for solution.
Warning
Intravenous route (Powder for Solution)
Do not substitute ado-trastuzumab emtansine with or for trastuzumab. Hepatotoxicity, liver failure, reductions in left ventricular ejection fraction, and death have occurred in ado-trastuzumab emtansine-treated patients. Monitor hepatic function and left ventricular function before beginning treatment and before each dose. Modify, hold, or discontinue treatment as necessary. Exposure to ado-trastuzumab emtansine during pregnancy can result in embryo-fetal harm. Advise patients of these risks and the need for effective contraception.
Serious side effects
Along with its needed effects, ado-trastuzumab emtansine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking ado-trastuzumab emtansine:
More common
- Black, tarry stools
- bladder pain
- bleeding gums
- bloating or swelling of the face, arms, hands, lower legs, or feet
- bloody or cloudy urine
- blurred vision
- burning, numbness, tingling, or painful sensations
- chills
- cough
- decreased urine
- difficult or labored breathing
- difficult, burning, or painful urination
- dizziness
- dry mouth
- fever
- frequent urge to urinate
- headache
- increased thirst
- irregular heartbeat
- loss of appetite
- lower back or side pain
- mood changes
- muscle pain or cramps
- nausea
- nervousness
- nosebleeds
- numbness or tingling in the hands, feet, or lips
- pale skin
- pinpoint red spots on the skin
- pounding in the ears
- rapid weight gain
- seizures
- slow or fast heartbeat
- sore throat
- stomach pain
- tightness in the chest
- troubled breathing with exertion
- ulcers, sores, or white spots in the mouth
- unsteadiness or awkwardness
- unusual bleeding or bruising
- unusual tiredness or weakness
- unusual weight gain or loss
- vomiting
- weakness in the arms, hands, legs, or feet
Less common
- Chest pain
- dilated neck veins
- extreme tiredness or weakness
- general feeling of discomfort or illness
- irregular breathing
- skin rash
- thickening of bronchial secretions
Rare
- Dark urine
- general feeling of tiredness or weakness
- light-colored stools
- stomach bloating
- vomiting blood
- yellow eyes or skin
Incidence not known
- Agitation
- confusion
- decreased awareness or responsiveness
- depression
- hostility
- irritability
- itching
- joint pain, stiffness, or swelling
- loss of consciousness
- muscle twitching
- severe sleepiness
- stomach tenderness or cramps
Other side effects
Some side effects of ado-trastuzumab emtansine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Belching
- change in taste
- constipation
- diarrhea
- difficulty with moving
- heartburn
- indigestion
- lack or loss of strength
- loss of taste
- muscle stiffness
- stomach discomfort or upset
- swelling or inflammation of the mouth
- trouble sleeping
Less common
- Burning, dry, or itching eyes
- discharge or excessive tearing
- redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
For Healthcare Professionals
Applies to ado-trastuzumab emtansine: intravenous powder for injection.
Cardiovascular
Common (1% to 10%): Left ventricular dysfunction, hypertension, peripheral edema[Ref]
Dermatologic
Very common (10% or more): Rash (12%)
Common (1% to 10%): Pruritus, alopecia, nail disorder, palmar-plantar erythrodysesthesia syndrome, urticaria[Ref]
Gastrointestinal
Very common (10% or more): Nausea (40%), constipation (24%), vomiting (20%), diarrhea (20%), dry mouth (16%), abdominal pain (16%), stomatitis (15%), stomatitis
Common (1% to 10%): Dyspepsia, gingival bleeding[Ref]
Genitourinary
Very common (10% or more): Urinary tract infection (12%)[Ref]
Hematologic
Very common (10% or more): Hemorrhage (35%), thrombocytopenia (25%), anemia (15%), hemorrhage
Common (1% to 10%): Neutropenia, leucopenia[Ref]
Hepatic
Very common (10% or more): Transaminases increased (12%)
Common (1% to 10%):
Uncommon (0.1% to 1%): Hepatotoxicity, hepatic failure, nodular regenerative hyperplasia, portal hypertension
Rare (0.01% to 0.1%): Portal hypertension, hepatic failure, nodular regenerative hyperplasia[Ref]
Hypersensitivity
Common (1% to 10%): Hypersensitivity[Ref]
Immunologic
Common (1% to 10%): Immunogenicity[Ref]
Metabolic
Very common (10% or more): Hypokalemia (11%)
Common (1% to 10%): Blood alkaline phosphatase increased[Ref]
Musculoskeletal
Very common (10% or more): Musculoskeletal pain (36%), arthralgia (19%), myalgia (13%)[Ref]
Nervous system
Very common (10% or more): Headache (28%), peripheral neuropathy (23%), asthenia, chills
Common (1% to 10%): Dizziness, dysgeusia, memory impairment[Ref]
Ocular
Common (1% to 10%): Dry eye, conjunctivitis, blurred vision, lacrimation increased[Ref]
Other
Very common (10% or more): Fatigue (37%), pyrexia (23%), asthenia (16%), chills (10%)[Ref]
Psychiatric
Very common (10% or more): Insomnia (12%)[Ref]
Respiratory
Very common (10% or more): Epistaxis (24%), cough (20%), dyspnea (13%)
Uncommon (0.1% to 1%): Pneumonitis[Ref]
Local
Uncommon (0.1% to 1%): Injection site extravasation, infusion-related reactions[Ref]